The U.S. Food and Drug Administration finalized guidance to help companies prepare to quickly and effectively remove violative products from the market. The guidance...
Inhibrx, Inc., a biotechnology company with four clinical programs in development and a strong emerging pipeline, announced that the U.S. Food and Drug Administration,...
AIkido Pharma Inc. reported an improvement in the manufacturing process for its pancreatic cancer drug, DHA-dFdC, licensed from the University of Texas at Austin....
IRALOGIX, a leading provider of cloud-based technology to enable institutional partners to rapidly offer a hands-on, engagement-focused IRA program to clients announced its partnership...
